Soleno Therapeutics stock dips on proposed $200M offering (SLNO:NASDAQ)
Soleno Therapeutics (NASDAQ:SLNO) shares fell nearly 10% premarket on Thursday after the company proposed an offering of $200 million of shares of its common stock. In addition, the biopharmaceutical company…
Share